In Spite of Dangers, Drug Firms Raise Prices

In spite of problems, drug companies have raised their prices almost 13% since 2003. The first half of this year, they’ve raised prices about 5.5%. As a response to impending Medicaid reform, drug companies have raised their prices, when greater pricing pressures are expected.